Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1190 studies found for:    Uterine Diseases: Clinical Trials
Show Display Options
Rank Status Study
21 Completed Aromatase Inhibitors or GnRH-a for Uterine Adenomyosis
Condition: the Efficacy of Aromatase Inhibitor vs. Gonadotrpins Releasing Hormone Agonists in Treating Premenopausal Women With Uterine Adenomyosis
Intervention: Drug: received oral letrozole (2.5 mg/day)and goserelin subcutaneosly (3.6 mg/month)
22 Active, not recruiting A Multicenter, Prospective, Randomized Trial of Adjuvant Chemotherapy for Early-Stage Cervical Cancer Patients
Conditions: Uterine Cervical Neoplasms;   Cervical Cancer;   Uterine Cervical Cancer
Interventions: Procedure: radical hysterectomy + pelvic lymph node dissection;   Drug: Paclitaxel;   Drug: Cisplatin;   Radiation: Pelvic RT
23 Recruiting RCT(Randomized Clinical Trial ) of Antibiotic Therapy in Chronic Endometritis
Condition: Chronic Endometritis
Interventions: Drug: antibiotics;   Drug: placebo
24 Completed
Has Results
Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological Tumors
Conditions: Primary Peritoneal Carcinoma;   Tumor;   Epithelial Ovarian Cancer;   Uterine Disease;   Cervix Diseases;   Neoplasms, Ovarian;   Cancer
Interventions: Drug: pazopanib (GW786034);   Drug: carboplatin;   Drug: paclitaxel
25 Completed Doxycycline Prophylaxis at Vacuum Aspiration Trial
Condition: Endometritis
Interventions: Drug: Doxycycline pre-operatively;   Drug: Doxycycline post-operatively
26 Unknown  Cervical Ripening Before Endometrial Biopsy in Abnormal Uterine Bleeding Using Sublingual Misoprostol
Condition: Abnormal Uterine Bleeding Unrelated to Menstrual Cycle
Interventions: Drug: Misoprostol;   Drug: Vitamin B6
27 Active, not recruiting Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer
Conditions: Recurrent Cervical Carcinoma;   Recurrent Uterine Corpus Carcinoma;   Recurrent Uterine Corpus Sarcoma;   Stage I Uterine Corpus Cancer;   Stage I Uterine Sarcoma;   Stage IA Cervical Cancer;   Stage IB Cervical Cancer;   Stage II Uterine Corpus Cancer;   Stage II Uterine Sarcoma;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage III Cervical Cancer;   Stage III Uterine Corpus Cancer;   Stage III Uterine Sarcoma;   Stage IV Uterine Corpus Cancer;   Stage IV Uterine Sarcoma;   Stage IVA Cervical Cancer;   Stage IVB Cervical Cancer
Interventions: Other: Medical Chart Review;   Other: Questionnaire Administration
28 Withdrawn A Phase II Clinical Trial of Chemo-radiotherapy in Combination With INO-3112 in Patients With Locally Advanced Cervical Cancer
Condition: Uterine Cervical Neoplasms
Interventions: Biological: INO-3112 vaccine;   Radiation: Radiotherapy (Extrernal beam radiotherapy + brachytherapy);   Drug: Cisplatin chemotherapy
29 Completed Laparoscopic Versus Robotic Assisted Laparoscopic Sacrocolpopexy for Vaginal Prolapse
Condition: Pelvic Organ Prolapse
Interventions: Procedure: robotic laparoscopic sacrocolpopexy;   Procedure: Laparoscopic Sacral Colpopexy
30 Not yet recruiting Mirena Extension Trial
Condition: Contraception
Intervention: Drug: Levonorgestrel IUS (Mirena, BAY86-5028)
31 Completed A Phase II Trial of Adjuvant Radiation Therapy With Ifosfamide in Patients With MMT of the Uterus
Condition: Uterine Cancer
Interventions: Drug: Ifosfamide;   Procedure: Radiation Therapy
32 Completed Comparison Between Transvaginal Mesh and Traditional Surgery for Pelvic Organ Prolapse
Condition: Vaginal Prolapse
Interventions: Procedure: Anterior colporrhaphy;   Procedure: Anterior PROLIFT
33 Completed Efficacy Study of Vaginal Mesh for Anterior Prolapse
Conditions: Vaginal Prolapse;   Uterine Prolapse;   Cystocele;   Pelvic Organ Prolapse
Intervention: Device: synthetic polypropylene mesh
34 Not yet recruiting The Potential for HPV Self-testing to Promote Participation in Cervical Screening
Condition: Cervix Diseases
Interventions: Procedure: Self-collecting a vaginal sample with a swab for HPV testing;   Procedure: Collection of cervical sample for routine cervical screening
35 Terminated Treatment of Unacceptable Bleeding Patterns in ETG Implant Users With an Oral Contraceptive
Conditions: Abnormal Uterine Bleeding, Unspecified;   Uterine Bleeding Heavy
Interventions: Drug: EE 30mcg/LNG 150mcg;   Drug: Placebo
36 Active, not recruiting Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
Conditions: Aids-related Malignancies;   Lymphoma;   Precancerous Condition;   Sarcoma
Interventions: Genetic: polymerase chain reaction;   Other: cytology specimen collection procedure;   Other: histological technique;   Procedure: colposcopic biopsy
37 Withdrawn Clinical Trial With Combination of Dienogest/Ethytnilestradiol and Drosperidona/Ethyniestradiol
Condition: Metrorrhagia
Intervention: Drug: barrier methods
38 Completed Randomized Controlled Trial Comparing Acellular Collagen Biomesh (Pelvisoft) to Polypropylene Mesh(Pelvitex) for Sacral Colpopexy
Condition: Uterine Prolapse
Intervention: Procedure: sacral colpopexy
39 Completed Uterotonic Efficacy of Oxytocin 2.5 Versus 10 Units During Caesarean Section at Mulago Hospital
Conditions: Adverse Effect of Oxytocic Drugs;   Uterine Hemorrhage;   Inappropriate Dose of Drug Administered
Interventions: Drug: 2.5 units Oxytocin;   Drug: 10 units Oxytocin
40 Completed Therapeutic Equivalence Trial of Two Hormonal-IUDs in Patients With Heavy Menstrual Bleeding
Condition: Heavy Menstrual Bleeding
Interventions: Drug: Levosert-20;   Drug: Mirena

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.